Prospective study for clinical effectiveness and safety of TAZ/PIPC for the prevention of infectious complication of high risk lung cancer surgery
Not Applicable
Recruiting
- Conditions
- Malignant lung tumor
- Registration Number
- JPRN-UMIN000003532
- Lead Sponsor
- Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with the medical history of hypersensitivity to penicillin 2)Patients who suffer from active infectious disease or were proven to be colonized by MRSA 3)Patients who have other malignant tumor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of the post-operative infectious complications
- Secondary Outcome Measures
Name Time Method 1 Safety 2 Rate of potentially or verified drug-resistant pathogen in the sputum collected by the post-operative bronchofiberscope